Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Safety Monitoring of mRNA Vaccines Administered During the Initial 6 Months of the U.S. COVID-19 Vaccination Program: Reports to Vaccine Adverse Events Reporting System (VAERS) and v-safe

Hannah G. Rosenblum, Julianne M. Gee, Ruiling Liu, Paige L. Marquez, Bicheng Zhang, Penelope Strid, Winston E. Abara, Michael M. McNeil, Tanya R. Myers, Anne M. Hause, John R. Su, Bethany Baer, David Menschik, Lauri E. Markowitz, Tom T. Shimabukuro, David K. Shay
doi: https://doi.org/10.1101/2021.10.26.21265261
Hannah G. Rosenblum
1CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia
2Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julianne M. Gee
1CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: eocevent416@cdc.gov
Ruiling Liu
1CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paige L. Marquez
1CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bicheng Zhang
1CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Penelope Strid
1CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Winston E. Abara
1CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael M. McNeil
1CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tanya R. Myers
1CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne M. Hause
1CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John R. Su
1CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bethany Baer
3Food and Drug Administration, Silver Spring, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Menschik
3Food and Drug Administration, Silver Spring, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lauri E. Markowitz
1CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tom T. Shimabukuro
1CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David K. Shay
1CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Data Availability

Data produced in the present study are available upon reasonable request to the authors

Back to top
PreviousNext
Posted October 28, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Safety Monitoring of mRNA Vaccines Administered During the Initial 6 Months of the U.S. COVID-19 Vaccination Program: Reports to Vaccine Adverse Events Reporting System (VAERS) and v-safe
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Safety Monitoring of mRNA Vaccines Administered During the Initial 6 Months of the U.S. COVID-19 Vaccination Program: Reports to Vaccine Adverse Events Reporting System (VAERS) and v-safe
Hannah G. Rosenblum, Julianne M. Gee, Ruiling Liu, Paige L. Marquez, Bicheng Zhang, Penelope Strid, Winston E. Abara, Michael M. McNeil, Tanya R. Myers, Anne M. Hause, John R. Su, Bethany Baer, David Menschik, Lauri E. Markowitz, Tom T. Shimabukuro, David K. Shay
medRxiv 2021.10.26.21265261; doi: https://doi.org/10.1101/2021.10.26.21265261
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Safety Monitoring of mRNA Vaccines Administered During the Initial 6 Months of the U.S. COVID-19 Vaccination Program: Reports to Vaccine Adverse Events Reporting System (VAERS) and v-safe
Hannah G. Rosenblum, Julianne M. Gee, Ruiling Liu, Paige L. Marquez, Bicheng Zhang, Penelope Strid, Winston E. Abara, Michael M. McNeil, Tanya R. Myers, Anne M. Hause, John R. Su, Bethany Baer, David Menschik, Lauri E. Markowitz, Tom T. Shimabukuro, David K. Shay
medRxiv 2021.10.26.21265261; doi: https://doi.org/10.1101/2021.10.26.21265261

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (179)
  • Allergy and Immunology (434)
  • Anesthesia (99)
  • Cardiovascular Medicine (948)
  • Dentistry and Oral Medicine (178)
  • Dermatology (110)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (422)
  • Epidemiology (8987)
  • Forensic Medicine (4)
  • Gastroenterology (420)
  • Genetic and Genomic Medicine (1958)
  • Geriatric Medicine (190)
  • Health Economics (402)
  • Health Informatics (1329)
  • Health Policy (660)
  • Health Systems and Quality Improvement (519)
  • Hematology (212)
  • HIV/AIDS (420)
  • Infectious Diseases (except HIV/AIDS) (10809)
  • Intensive Care and Critical Care Medicine (575)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (222)
  • Neurology (1830)
  • Nursing (110)
  • Nutrition (274)
  • Obstetrics and Gynecology (353)
  • Occupational and Environmental Health (470)
  • Oncology (999)
  • Ophthalmology (298)
  • Orthopedics (111)
  • Otolaryngology (182)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (580)
  • Pharmacology and Therapeutics (276)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1903)
  • Public and Global Health (4123)
  • Radiology and Imaging (676)
  • Rehabilitation Medicine and Physical Therapy (368)
  • Respiratory Medicine (549)
  • Rheumatology (225)
  • Sexual and Reproductive Health (191)
  • Sports Medicine (177)
  • Surgery (207)
  • Toxicology (39)
  • Transplantation (109)
  • Urology (81)